Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:37:03 EST Fri 06 Feb 2026
Enter Symbol
or Name
USA
CA



Q:RIGL - RIGEL PHARMACEUTICALS INC - https://rigel.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RIGL - Q0.129.27·44.000.434.15+0.932.8353.911,7794,98633.46  35.00  33.4652.055  15.5019:20:42Feb 0315 min RT 2¢

Recent Trades - Last 10 of 4986
Time ETExPriceChangeVolume
19:20:42Q34.150.935
19:17:41Q34.150.932
19:16:39Q34.150.933
16:10:04Q34.150.931
16:10:04Q34.150.931
16:04:17Q34.150.931
16:04:14Q34.150.931
16:04:14Q34.150.931
16:04:02Q34.150.931
16:02:32Q34.150.93132

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-03 08:05U:RIGLNews ReleaseRigel Appoints Michael P. Miller to the Board of Directors
2026-01-12 08:05U:RIGLNews ReleaseRigel Provides Business Update and 2026 Outlook
2026-01-09 08:05U:RIGLNews ReleaseRigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2026-01-07 08:05U:RIGLNews ReleaseRigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-07 09:30U:RIGLNews ReleaseRigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
2025-11-26 08:05U:RIGLNews ReleaseRigel to Present at the Piper Sandler 37th Annual Healthcare Conference
2025-11-17 08:05U:RIGLNews ReleaseRigel Announces Publication of Final 5-year Data on REZLIDHIA(TM) (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
2025-11-12 08:05U:RIGLNews ReleaseRigel to Present at the Jefferies Global Healthcare Conference in London
2025-11-04 16:01U:RIGLNews ReleaseRigel Reports Third Quarter 2025 Financial Results and Provides Business Update
2025-11-03 09:05U:RIGLNews ReleaseRigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
2025-10-29 08:05U:RIGLNews ReleaseRigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update
2025-10-08 08:05U:RIGLNews ReleaseRigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS
2025-10-03 08:05U:RIGLNews ReleaseRigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2025-08-26 08:05U:RIGLNews ReleaseRigel to Participate in Upcoming September Investor Conferences
2025-08-05 16:01U:RIGLNews ReleaseRigel Reports Second Quarter 2025 Financial Results and Provides Business Update
2025-07-29 08:05U:RIGLNews ReleaseRigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update
2025-07-07 08:05U:RIGLNews ReleaseRigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2025-05-28 08:05U:RIGLNews ReleaseRigel to Present at the Jefferies Global Healthcare Conference
2025-05-22 17:20U:RIGLNews ReleaseRigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress
2025-05-06 16:01U:RIGLNews ReleaseRigel Reports First Quarter 2025 Financial Results and Provides Business Update